atopic-dermatitis

Documents about atopic-dermatitis

• A Study to Evaluate the Efficacy and Safety of AK139 in Patients With Moderate-to-severe Atopic Dermatitis#846163ClinicalTrials.gov
• A Phase I/IIa Study to Investigate the GM-XANTHO in Healthy Volunteers and Atopic Dermatitis Patients#854785ClinicalTrials.gov
• Long-Term Safety and Efficacy Evaluation of Amlitelimab in Participants of Previous Amlitelimab Moderate to Severe Atopic Dermatitis Clinical Trials#865139ClinicalTrials.gov
• Creation of a Shared Medical Decision-making Tool for Atopic Dermatitis#886214ClinicalTrials.gov
• A Study of Lebrikizumab (LY3650150) on Vaccine Response in Adults With Atopic Dermatitis (ADopt-VA)#906635ClinicalTrials.gov
• A Study of SHR-1819 Injection in Adolescents With Severe Atopic Dermatitis#917381ClinicalTrials.gov
• Severe Atopic Dermatitis Treated by Wet Wrapping: An Observation at the Dermatology Hospital of Bamako (Mali)#929722Clinical Journal of Nursing Care and Practice
• Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic Dermatitis#982485ClinicalTrials.gov
• Study of Generic Pimecrolimus Cream, 1% in the Treatment of Mild to Moderate Atopic Dermatitis#1032613ClinicalTrials.gov
• Study Of PF-06817024 In Healthy Subjects, In Patients With Chronic Rhinosinusitis With Nasal Polyps And in Patients With Atopic Dermatitis#916891ClinicalTrials.gov
• Study of Eblasakimab in Male or Female Moderate-to-Severe Atopic Dermatitis Patients Previously Treated With Dupilumab#969605ClinicalTrials.gov
• Atopic dermatitis and the risk of osteoporosis and fractures: a meta-analysis of cohort studies#4759Europe PMC
• Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)#802325ClinicalTrials.gov
• Maternal Key Nutritional Factors and Offspring's Atopic Dermatitis (MKNFOAD)#828288ClinicalTrials.gov
• Atopic Dermatitis Cutaneous Discomfort of the Infant Under the Age of One Year : Analysis of Filmed Sequences (PRE-PRURINEO)#831043ClinicalTrials.gov
• A Study Assessing Rocatinlimab (AMG 451) Monotherapy in Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-Horizon)#833070ClinicalTrials.gov
• A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis#836936ClinicalTrials.gov
• A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of Upadacitinib in Pediatric Participants With Severe Atopic Dermatitis#847256ClinicalTrials.gov
• Blinded, Randomized Study Evaluating Aurstat Versus Control in the Treatment of Atopic Dermatitis Associated Pruritus#884450ClinicalTrials.gov
• Open Label, Drug-Drug Interaction (DDI) Study of Dupilumab (REGN668/SAR231893) in Patients With Moderate to Severe Atopic Dermatitis (AD)#904790ClinicalTrials.gov
• Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments#905907ClinicalTrials.gov
• Atopic Dermatitis (AD) and Food Allergy#834061ClinicalTrials.gov
• DIETARY FACTORS AND THEIR INFLUENCES ON ATOPIC DERMATITIS: INTEGRATING CROSS–SECTIONAL, LONGITUDINAL, AND RANDOMIZED CONTROLLED TRIAL APPROACHES#190101ScholarBank@NUS
• DIETARY FACTORS AND THEIR INFLUENCES ON ATOPIC DERMATITIS: INTEGRATING CROSS–SECTIONAL, LONGITUDINAL, AND RANDOMIZED CONTROLLED TRIAL APPROACHES#190571ScholarBank@NUS
• Effects of a Mixed Chinese Herbal Formula on Atopic Dermatitis#827372ClinicalTrials.gov
• A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis#830097ClinicalTrials.gov
• A Study to Evaluate Microneedle-based Collection of Dermal Interstitial Skin Fluid in Healthy Participants and Atopic Dermatitis Participants#836484ClinicalTrials.gov
• Study of an Anti-OX40 Monoclonal Antibody (KHK4083) in Subjects With Moderate to Severe Atopic Dermatitis#981573ClinicalTrials.gov
• A Study to Evaluate Adverse Events and Change in Disease State of Oral Upadacitinib in Adolescent Participants Ages 12 to <18 Years Old Diagnosed With Atopic Dermatitis (AD)#857598ClinicalTrials.gov
• Double-Blind, Parallel, Randomised Study to Investigate the Effect of Oral Probiotics in Infants With Atopic Dermatitis#864688ClinicalTrials.gov
• Immunomodulatory and anti-inflammatory effects of agave fructans in atopic dermatitis: gut microbiota and short-chain fatty acid implication#7702HAL (France)
• Effects of a Berry Oil Cream on Atopic Eczema and Skin#878715ClinicalTrials.gov
• The Effect of a Probiotic Intervention in Healthy Subjects and Patients With Atopic Dermatitis#803734ClinicalTrials.gov
• Phase 2a, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of EP262 in Subjects With Atopic Dermatitis#845579ClinicalTrials.gov
• Targeted Investigation of Microbiome 2 Treat Atopic Dermatitis (TIME-2)#852504ClinicalTrials.gov
• Can Vitamin D Treatment Help Treat Moderate to Severe Atopic Dermatitis in Young Children? the D-Vex Pilot Study#867564ClinicalTrials.gov
• A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic Dermatitis#868473ClinicalTrials.gov
• A Study of Lebrikizumab (LY3650150) in Adult and Adolescent Participants With Moderate-to-Severe Atopic Dermatitis Previously Treated With Dupilumab#895518ClinicalTrials.gov
• Study to Assess the Clinical Activity of a Sequential Dose of REGN846 on Refractory Pruritus in Patients With Atopic Dermatitis#899532ClinicalTrials.gov
• A Study to Evaluate the Safety and Tolerability of Multiple Dose of IBI3002 in Patients With Atopic Dermatitis#906837ClinicalTrials.gov
• TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis#1010588ClinicalTrials.gov
• Psychiatric Problems in Chronic Skin Diseases#906085ClinicalTrials.gov
• Registry for Systemic Eczema Treatments#905511ClinicalTrials.gov
• A Study to Evaluate the Effectiveness and Safety of Treatments, Either Alone or in Combination, for the Treatment of Moderate to Severe Atopic Dermatitis#837214ClinicalTrials.gov
• Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥2 Years With Mild to Moderate Atopic Dermatitis#858484ClinicalTrials.gov
• The Effect of Gladskin on Disease Severity and the Skin Microbiome, Including Staphylococcus Aureus, in Patients With Atopic Dermatitis#865097ClinicalTrials.gov
• Study to Assess the Long-term Safety of Dupilumab Administered in Participants ≥6 Months to <18 Years of Age With Atopic Dermatitis (AD)#882042ClinicalTrials.gov
• A Study to Investigate the Safety, Tolerability, and Efficacy of BxC-I17e Repeated-dose SC Injection in Patients With Moderate to Severe Atopic Dermatitis#883626ClinicalTrials.gov
• A Study to Assess the Safety, Tolerability, and Efficacy of Rocatinlimab in Adolescent Participants With Moderate-to-severe Atopic Dermatitis (AD)#894704ClinicalTrials.gov
• A Dose-ranging Study to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of Galvokimig in Adult Study Participants With Atopic Dermatitis#911211ClinicalTrials.gov